Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Information Services
- Sub-Industry: Health Care Technology
- Exchange: NASDAQ
- Symbol: OMCL
- CUSIP: 68213N10
- Previous Close: $38.15
- 50 Day Moving Average: $35.63
- 200 Day Moving Average: $35.63
- 52-Week Range: $25.06 - $40.50
- Trailing P/E Ratio: 2244.12
- Foreward P/E Ratio: 18.43
- P/E Growth: 1.70
- Market Cap: $1.39B
- Outstanding Shares: 36,553,000
- Beta: 0.76
- Net Margins: 1.24%
- Return on Equity: 10.74%
- Return on Assets: 5.31%
Companies Related to Omnicell:
- Debt-to-Equity Ratio: 0.50%
- Current Ratio: 1.70%
- Quick Ratio: 1.33%
What is Omnicell's stock symbol?
Omnicell trades on the NASDAQ under the ticker symbol "OMCL."
Where is Omnicell's stock going? Where will Omnicell's stock price be in 2017?
7 equities research analysts have issued 12-month price objectives for Omnicell's shares. Their predictions range from $37.00 to $55.00. On average, they expect Omnicell's share price to reach $43.71 in the next twelve months.
When will Omnicell announce their earnings?
Omnicell is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.
Who owns Omnicell stock?
Omnicell's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (4.93%), Champlain Investment Partners LLC (4.38%), State Street Corp (2.20%), Thrivent Financial for Lutherans (1.67%), Edge Asset Management Inc. (1.08%) and Westwood Holdings Group Inc. (1.03%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, J Christopher Drew, James T Judson, Jorge R Taborga, Nhat H Ngo, Randall A Lipps, Robin Gene Seim and Sara J White.
Who sold Omnicell stock? Who is selling Omnicell stock?
Omnicell's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Axiom International Investors LLC DE, State Board of Administration of Florida Retirement System, Nicholas Co. Inc. WI, Teachers Retirement System of The State of Kentucky, Edge Asset Management Inc., Kopp Investment Advisors LLC and Lyon Street Capital LLC. Company insiders that have sold Omnicell stock in the last year include Dan S Johnston, Gary S Petersmeyer, J Christopher Drew, James T Judson, Jorge R Taborga, Randall A Lipps, Robin Gene Seim and Sara J White.
Who bought Omnicell stock? Who is buying Omnicell stock?
Omnicell's stock was bought by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Westwood Holdings Group Inc., State Street Corp, Martingale Asset Management L P, Russell Investments Group Ltd., Dimensional Fund Advisors LP, Bessemer Group Inc. and Renaissance Technologies LLC.
How do I buy Omnicell stock?
Shares of Omnicell can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Omnicell stock cost?
One share of Omnicell stock can currently be purchased for approximately $38.15.